M&I Teresa O'Meara is a recipient of of the Investigators in the Pathogenesis of Infectious Disease (PATH) program of the Burroughs Wellcome Fund. Her lab will further study the mechanisms of attachment and virulence for C. auris, with a focus on how the novel adhesin contributes to pathogenesis. On a practical level, their work will suggest strategies for developing vaccine candidates and therapeutics to limit disease caused by this emerging pathogen.

A study published by researchers at the University of Michigan reveals that implementing this screening tool can help identify and support youth with firearm violence history.

On May 16, 2024, the Regents of the University of Michigan promoted Melanie Pearson, Ph.D., to Associate Professor on the Research Track, effective September 1, 2024.

Faith Anderson, Jaime Fuentes, and Andrés Rivera Ruiz, M&I Ph.D. candidates, have been awarded prestigious fellowships from Rackham Graduate School, in recognition of their academic excellence. Congratulations, we’re so proud of you!

A melanoma survivor shares facts and tips about preventing all types of skin cancer.

In emergency rooms and intensive care units across the country, clinicians make split-second decisions about which antibiotics to give a patient when a life threatening infection is suspected. Now, a study reveals that these decisions may have unintended consequences for patient outcomes.

In the second season of The Fundamentals podcast, co-hosts Kelly Malcom and Jordan Goebig talk to several leading experts from the Medical School about their fields and the fundamental questions they are trying to answer — and discover why U-M is such an amazing place for research. Six new episodes of the popular podcast were released on May 6

A study builds on previous work that found depriving T cells of iron prevented cells from proliferating. The current study, published in PNAS, found that excess iron is just as problematic.

On today’s The Fundamentals is Dr. Brummett, Professor at the University of Michigan where he serves as the Senior Associate Chair for Research in the Department of Anesthesiology. He has more than 280 publications, including articles in top journals such as JAMA, JAMA Surgery, Anesthesiology, and Annals of Surgery. He is the Co-Director of the Opioid Prescribing Engagement Network or OPEN at the University of Michigan, which aims to apply a preventative approach to the opioid epidemic in the US through appropriate prescribing after surgery, dentistry and emergency medicine. Moreover, he is the Co-Director of the cross-campus Opioid Research Institute, which was launched in the spring of 2023. He leads multiple NIH grants studying these concepts and receives funding from the Michigan Department of Health and Human Services, SAMHSA, CDC, and multiple foundations. You can learn more about Dr. Brummett here, and you can follow Dr. Brummett @drchadb and the department of anesthesiology @UMichAnesthesia on X.

Today on The Fundamentals, our guest is Dr. Michelle Kahlenberg, an Associate Professor of Internal Medicine and Dermatology, the Giles Bole and Dorothy Mulkey Research Professor of Rheumatology and the Vice Chair for Basic and Translational Research in Internal Medicine. Her clinical work is centered on the care of patients with lupus, including those with refractory skin disease. In addition to running her lab, she's an active member of the Immunology Training Program and has received national recognition for her research.

Four Graduate Program in Immunology alumni participated in a panel discussion about their career paths.

This M&I award recognizes outstanding dissertations.

A survey focused on how much people in their teens and early 20s know about periods and their experience and attitudes around “period poverty”.

The Clinical Trials Support Office (CTSO) is pleased to announce that Mio Nakamura, MD, MS, Clinical Assistant Professor, Dermatology, has been appointed as the new Associate Medical Director of the Michigan Clinical Trials Support Unit (M-CTSU) and Michigan Clinical Research Unit (MCRU). Dr. Nakamura’s appointment will begin July 1, 2024, and is a 2-year term.

M&I grant administration team attends and presents at the National Council for University Research Administrators (NCURA) conferences